Enantioselective Thiourea-Catalyzed Syntheses of beta-Lactones and beta-Lactams
Enantioselective Thiourea-Catalyzed Syntheses of beta-Lactones and beta-Lactams
批准号:
8386192
负责人:
Pamela Michele Tadross
金额:
$4.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-12-01 至 2014-11-30
关键词:
AddressAldehydesAmino AcidsBiological FactorsCapromycinCarbonCephalexinClinicalCommunicable DiseasesCyclizationDevelopmentDiseaseGoalsIminesInfectionKetonesLactamsLactonesLeadMediatingMethodologyMethodsOrganic ChemistryPenicillinsPharmaceutical PreparationsPharmacologic SubstancePhasePreparationProcessReactionResearchSchering-Plough brand of ezetimibeStructureThioureaUbenimexUrsidae FamilyXenicalbeta-Lactamscancer therapycatalystcycloadditiondesignenolate
中文摘要
描述(申请人提供):内酯和-内酰胺是治疗疾病和感染的关键结构基序,其活性与各自存在的高度紧张的四元环直接相关。除了在临床环境中的应用,这些化合物还是制备其他医学上重要结构的有价值的起始材料,如氨基酸。尽管高取代内酯和内酰胺类化合物的催化不对称构筑方法很重要,但它们在底物范围、催化剂设计和通用性方面都受到限制。为了克服这些限制,本提案提供了一种催化对映体选择性方法,利用双功能硫脲催化剂从简单、无手性和容易获得的原料中一步制备内酯和内酰胺类化合物。具体地说,硫脲催化剂将介导酮与醛、酮和亚胺之间的正式[2+2]环加成反应。通过这个过程,可以产生一系列不同的产品,其中含有邻近的立体生成碳。此外,亚膦硫脲催化剂的应用将允许两个反应伙伴的协同活化,以最大程度收敛的方式在两个复杂性大致相同的化合物之间形成新的C-C和C-杂原子键。将该方法生成的内酯和内酰胺产品应用于天然产物的全合成和重要医药衍生物的制备,将为开发治疗癌症和传染病的新药物提供重要的先导化合物。
英文摘要
DESCRIPTION (provided by applicant): Lactones and -lactams are structural motifs critical to the treatment of disease and infection whose activity is directly related to the highly strained 4-membered ring present in each. Beyond their applications in clinical settings, these compounds are valuable starting materials for the preparation of other medicinally important structures, such as -amino acids. Despite their importance, methods for the catalytic enantioselective construction of highly substituted -lactones and -lactams are limited with regard to substrate scope, catalyst design, and generality. To address these limitations, the current proposal provides a catalytic enantioselective method for the preparation of both -lactones and -lactams in a single step from simple, achiral, and readily available starting materials using a bifunctional phosphinothiourea catalyst. Specifically, the thiourea catalyst will mediate the formal [2+2] cycloaddition reaction between ketenes and aldehydes, ketones, and imines. By this process, a diverse array of products can be generated that bear vicinal stereogenic carbons. Furthermore, the application of a phosphinothiourea catalyst will allow cooperative activation of both reaction partners, forming new C-C and C-heteroatom bonds between two compounds of roughly equal complexity in a maximally convergent fashion. The application of -lactone and -lactam products generated by this method to the total synthesis of natural products and to the preparation of medicinally important derivatives will provide access to important lead compounds for the development of new pharmaceutical agents for the treatment of cancer and infectious disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enantioselective Thiourea-Catalyzed Syntheses of beta-Lactones and beta-Lactams
-
批准号:8122804
-
项目类别:
-
资助金额:$4.63万
-
财政年份:2011
-
负责人:Pamela Michele Tadross
-
依托单位:
海外基金